Migraine with aura
Therapeutic area
Neurology
Rare disease
No
- Definition
- A migraine disorder characterized by episodes that are preceded by focal neurological symptoms.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Migraine with aura
- Alternative names
- migraine with aura
- Therapeutic area
- Neurology
- Severity
- Mild
- Cardiology
- Neurology
- Vascular Medicine
- MONDO ID
- MONDO:0005475
- Parent condition
- MONDO:0005277
Related records
Broader conditions (13)
- Brain disorder
- Cardiovascular disorder
- Central nervous system disorder
- Disease
- Disease by body system or component
- Headache disorder
- Human disease
- Hypnic headache
- Migraine disorder
- Nervous system disorder
- Neurological pain disorder
- Neurovascular disorder
- Vascular disorder
Narrower conditions (9)
- Familial hemiplegic migraine
- Familial or sporadic hemiplegic migraine
- Hemiplegic migraine-developmental and epileptic encephalopathy spectrum
- Migraine with brainstem aura
- Migraine, familial hemiplegic, 1
- Migraine, familial hemiplegic, 2
- Migraine, familial hemiplegic, 3
- Migraine, familial hemiplegic, 4
- Sporadic hemiplegic migraine
Trials (113)
- A Comprehensive Digital Care Program for Migraine Management
- A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
- A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
- A Study of a Melatonin Receptor Agonist to Prevent Migraine
- A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
- A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
- A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
- A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
- A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
- Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
- Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
- App-Based Migraine Treatment: The Health enSuite Study
- Aspirin Resistance in Women With Migraine
- Assessment of Inflammation in Primary Headaches
- BE WELL With Migraine: Brain Education and WELLness With Migraine
- Botox Injection in Treatment of Chronic Migraine
Drugs in development (17)
- Amiloride Phase 2
- Anisodine hydrobromide Phase 3
- Caffeine Phase 3
- Candesartan Phase 2
- Dihydroergotamine Phase 3
- Dronabinol Phase 2
- Eletriptan Phase 3
- Promethazine Phase 3
- Propranolol Phase 2
- Ramelteon Phase 2
- Rizatriptan Phase 3
- Rizatriptan benzoate Phase 3
- Sildenafil Early phase 1
- Sumatriptan Phase 3
- Sumatriptan succinate Phase 3
- Tizanidine hydrochloride Phase 3
- Tonabersat Phase 2
Other linked drugs (3)
- Endothelin
- Naproxen
- Topiramate